Evidence map›Paper›PMID 25193959›Full record

ArticleHaematologica2014

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.

Christopher P Venner, Julian D Gillmore, Sajitha Sachchithanantham, Shameem Mahmood, Thirusha Lane, Darren Foard, Murielle Roussel, Lisa Rannigan, Simon Dj Gibbs, Jennifer H Pinney and 4 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. AL amyloidosis: untangling new therapies.Hematology. American Society of Hematology. Education Program · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2016
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Christopher P VennerNational Amyloidosis Centre, University College London Medical School, UK Cross Cancer Institute, University of Alberta, Edmonton, Canada.
Julian D GillmoreNational Amyloidosis Centre, University College London Medical School, UK.
Sajitha SachchithananthamNational Amyloidosis Centre, University College London Medical School, UK.
Shameem MahmoodNational Amyloidosis Centre, University College London Medical School, UK.
Thirusha LaneNational Amyloidosis Centre, University College London Medical School, UK.
Darren FoardNational Amyloidosis Centre, University College London Medical School, UK.
Murielle RousselHématologie Clinique, CHU Purpan, Toulouse, France.
Lisa RanniganNational Amyloidosis Centre, University College London Medical School, UK.
Simon Dj GibbsNational Amyloidosis Centre, University College London Medical School, UK Central Manchester University Hospital, Department of Clinical Haematology, Manchester, UK.
Jennifer H PinneyNational Amyloidosis Centre, University College London Medical School, UK.
Carol J WhelanNational Amyloidosis Centre, University College London Medical School, UK.
Helen J LachmannNational Amyloidosis Centre, University College London Medical School, UK.
Philip N HawkinsNational Amyloidosis Centre, University College London Medical School, UK.
Ashutosh D WechalekarNational Amyloidosis Centre, University College London Medical School, UK a.wechalekar@ucl.ac.uk.
University College London · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationImmunoglobulin Light ChainsPatient SelectionAdultAgedAmyloidosisAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesCombined Modality TherapyFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingImmunoglobulin Light Chainsamyloidosispatient selectionstem cell transplantation

Identifiers

PMID25193959
PMCPMC4258758
OpenAlexW2100545079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.